Water Tower Research Publishes Initiation of Coverage Report on InMed Pharmaceuticals, Inc. Titled “A Unique Developer of Rare Cannabinoid-Based Therapies”

Press Release Apr 26, 2023

April 26, 2023, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on InMed Pharmaceuticals, Inc. (NASDAQ: INM) titled, “A Unique Developer of Rare Cannabinoid-Based Therapies”. The report can be accessed here. Vancouver-headquartered and […]

Tag: rare cannabinoids

Water Tower Research Publishes Initiation of Coverage Report on InMed Pharmaceuticals, Inc. Titled “A Unique Developer of Rare Cannabinoid-Based Therapies”

Cookies & Privacy